Crypto asset converter Bio Protocol to Euro
Easily convert Bio Protocol to Euro with our calculator. See the conversion trend and key exchange rates between BIO and EUR.
Cryptocurrency Converter
Bio Protocol to EUR — Market data
Market cap
58.71M€
24h Volume
25.58M€
Max supply
3.32B
Circulating supply
3.32B
Type
currency
Price of BIO/EUR - Bio Protocol/Euro
The price of Bio Protocol is rising
The value of Bio Protocol is 0,0273€. That means, to purchase 5 BIO, you will need to pay 0,1366€. On the other hand, with 1,00€, you can buy a total of 36.58982803 BIO, while 50,00€ would allow you to make an acquisition of 1,829.49140139 BIO.
In the last 7 days, the price of Bio Protocol has increased by +10.88%. Meanwhile, in the last 24 hours, the price has changed by +8.19%.
Convert BIO to EUR
| Amount | 06/12/2026, 02:11 AM |
|---|---|
| 0.5 BIO | 0,0137€ |
| 1 BIO | 0,0273€ |
| 2 BIO | 0,0547€ |
| 5 BIO | 0,1366€ |
| 10 BIO | 0,2733€ |
| 50 BIO | 1,37€ |
| 100 BIO | 2,73€ |
| 500 BIO | 13,67€ |
| 1000 BIO | 27,33€ |
Convert EUR to BIO
| Amount | 06/12/2026, 02:11 AM |
|---|---|
| 0,5000€ | 0.01366500 BIO |
| 1,00€ | 0.02733000 BIO |
| 2,00€ | 0.05466000 BIO |
| 5,00€ | 0.13665000 BIO |
| 10,00€ | 0.27330000 BIO |
| 50,00€ | 1.36650000 BIO |
| 100,00€ | 2.73300000 BIO |
| 500,00€ | 13.66500000 BIO |
| 1.000,00€ | 27.33000000 BIO |
Buy Bio Protocol safely
Sign up with Bit2Me and access the most trusted cryptocurrency exchange platform to buy and sell Bio Protocol securely.
What is Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
